World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
30806
World Ranking
10916
National Ranking
5615

Wayne L. Hofstetter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Wayne L. Hofstetter sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 520 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Wayne L. Hofstetter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Wayne L. Hofstetter sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Wayne L. Hofstetter is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical disciplines, with a strong emphasis on pulmonary and respiratory medicine, surgery, and oncology. Additional expertise lies in molecular biology and radiology, nuclear medicine, and imaging.

Themes central to Hofstetter's work include esophageal cancer research and treatment, gastric cancer management and outcomes, as well as lung cancer diagnosis and treatment. Their publications also cover esophageal and gastrointestinal pathology, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, and pleural and pulmonary diseases.

Hofstetter has contributed extensively to scientific literature, particularly in clinical and surgical oncology. Frequent publication venues for their work include:

  • Journal of Thoracic and Cardiovascular Surgery
  • The Annals of Thoracic Surgery
  • Journal of Surgical Oncology
  • Diseases of the Esophagus
  • Journal of Clinical Oncology

Several coauthors frequently collaborate with Hofstetter, including:

  • David C. Rice
  • Ara A. Vaporciyan
  • Reza J. Mehran
  • Stephen G. Swisher
  • Boris Sepesi

Highlighted recent publications authored or coauthored by Hofstetter include:

  • Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, Nature Medicine
  • Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology, 2023, Journal of the National Comprehensive Cancer Network
  • Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline, 2020, Journal of Clinical Oncology
  • Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer, 2020, Journal of Clinical Oncology

Best Publications

  • International consensus on standardization of data collection for complications associated with esophagectomy: Esophagectomy Complications Consensus Group (ECCG)

    Donald E. Low;Derek Alderson;Ivan Cecconello;Andrew C. Chang

  • Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Jaffer A. Ajani;Thomas A. D'Amico;David J. Bentrem;Joseph Chao

  • Benchmarking Complications Associated with Esophagectomy.

    Donald E. Low;Madhan Kumar Kuppusamy;Derek Alderson;Ivan Cecconello

  • Gastric Cancer, Version 2.2013

    Jaffer A. Ajani;David J. Bentrem;Stephen Besh;Thomas A. D'Amico

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.

    Tina Cascone;William N. William;Annikka Weissferdt;Cheuk H. Leung

  • Optimum lymphadenectomy for esophageal cancer.

    Nabil P. Rizk;Hemant Ishwaran;Thomas W. Rice;Long Qi Chen

  • Esophageal and esophagogastric junction cancers, version 1.2015.

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Treatment Outcomes of Resected Esophageal Cancer

    Wayne Hofstetter;Stephen G. Swisher;Arlene M. Correa;Kenneth Hess

  • Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

    Charles S. Cleeland;Xin Shelley Wang;Qiuling Shi;Tito R. Mendoza

  • Esophageal and Esophagogastric Junction Cancers

    Jaffer A. Ajani;James S. Barthel;David J. Bentrem;Thomas A. D'Amico

  • Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer

    Steven Hsesheng Lin;Lu Wang;Bevan Myles;Peter F Thall

  • Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.

    T. W. Rice;H. Ishwaran;W. L. Hofstetter;D. P. Kelsen

  • Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Thomas W. Rice;Donna M. Gress;Deepa T. Patil;Wayne L. Hofstetter

  • Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis

    Nirav Thosani;Harvinder Singh;Asha Kapadia;Nobuo Ochi

  • Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.

    Kim L. Wang;Tsung-Teh Wu;In Seon Choi;Huamin Wang

  • Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

    David C. Rice;Craig W. Stevens;Arlene M. Correa;Ara A. Vaporciyan

  • Hippo coactivator YAP1 upregulates SOX9 and endows esophageal Cancer cells with stem-like properties

    Shumei Song;Jaffer A Ajani;Soichiro Honjo;Dipen Maheshbhai Maru

  • Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.

    Lixia Liu;Wayne L. Hofstetter;Asif Rashid;Stephen G. Swisher

  • The hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer

    Shumei Song;Soichiro Honjo;Jiankang Jin;Shih Shin Chang

Frequent Co-Authors

Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center
Garrett L. Walsh
Garrett L. Walsh The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if medical school is the only option? There are a variety of online degrees and pathways in the health field that can lead to rewarding careers, many of which have flexible entry requirements and shorter study times.

Becoming a Registered Nurse is one of the most popular alternatives. For those looking for an accessible path, check out some of the easiest rn program to get into. Some nursing schools are also more accessible because they are nursing schools that don't require teas test, making them an excellent choice if you’re concerned about entrance exams.

If administration interests you, explore fully online healthcare administration degrees that can prepare you for leadership and management roles. Alternatively, consider a specialized field such as medical billing and coding, where you might qualify for financial aid for medical billing and coding online classes.

These alternative pathways offer the flexibility and accessibility many students seek, helping you start a health-focused career in less time and often at a lower cost.

Best Scientists Citing Wayne L. Hofstetter

Trending Scientists

Recently Published Articles